Update (June 28, 2018): Cannabis is added to Schedule II of the Natural Health Product Regulations. Contact us for further information. 1-866-647-3279 or email@example.com.
Update (June 28, 2018): CBD as a concentrate, isolate, or as a synthetic duplicate will not be regulated under the Cannabis Act.
CBD comes from both hemp and psychoactive cannabis.
Hemp is commercially grown for its seeds and stalks, and is very low in THC – no more than 0.3% by dry weight. Unlike marijuana, hemp is naturally higher in cannabidiol (CBD). It is a non-psychoactive and therefore won’t cause a high- making it safe for use by anyone.
Licensed Producers will continue to extract CBD from marijuana plants, however most of the promoted products contain some minor level of THC and therefore will continue to be sold through LPs.
It was believed that CBD products derived from Hemp would be classified as natural health products, and therefore would not follow the new Cannabis Act (however, this is not currently the case). As a natural health product, companies would only require a Natural Product Number (NPN) for each product and a Site Licence to import, package, label or manufacture nutraceuticals, cosmetics, foods and beverages with CBD. Global interest in products containing CBD will continue to grow at a rapid pace. dicentra, as a full service consultancy, has natural health products and cannabis experience since 2002. Call us with your questions at 1-866-647-3279.